Menu
BlackStone Therapeutics is a leader in cannabis-based research. Our research team has over 50 years of chemical experience ranging from academia, pharmaceutical, and industrial laboratories. The staff chemists have experience with: oxidations, reductions, protections, olefinations, organotransition metal chemistry, enolate chemistry, and photochemistry. The Research and Development team holds several pending patents on novel cannabinoids and has promising oncology studies heading into in vivo animal studies.
BlackStone Therapeutics has collaborations with Colorado Chromatography Labs, Wayne State University Karmanos Cancer Institute, University of Wyoming School of Pharmacy, University of New Mexico, and University of the Incarnate Word.
BlackStone Therapeutics is a leader in cannabis-based research. Our research team has over 50 years of chemical experience ranging from academia, pharmaceutical, and industrial laboratories. The staff chemists have experience with: oxidations, reductions, protections, olefinations, organotransition metal chemistry, enolate chemistry, and photochemistry. The Research and Development team holds several pending patents on novel cannabinoids and has promising oncology studies heading into in vivo animal studies.
BlackStone Therapeutics has collaborations with Colorado Chromatography Labs, Wayne State University Karmanos Cancer Institute, University of Wyoming School of Pharmacy, University of New Mexico, and University of the Incarnate Word.
Collins, A. C., Ray, K. P., Cruces, W., Patent Pending, PCT/US22/74054, July 22, 2022
Collins, A.C., Ray, K. P., Cruces, W., Patent Pending, PCT/US22/74047, July 22, 2022
Cruces, W., Ray, K. P., Jagtap, P. G., Patent Pending, 63/411,506, September 29, 2022
Tesfatsion, T. T., Ramirez, G. A., Collins, A. C., Mzannar, Y., Khan, H. Y., Aboukameel, O., Azmi, A. S., Jagtap, P. G., Ray, K. P., Cruces, W., Antineoplastic Properties of THCV, HHC and their anti-Proliferative effects on HPAF-II, MIA-paca2, Aspc-1, and PANC-1 PDAC Pancreatic Cell Lines, Preprint: doi.org/10.26434/chemrxiv-
In addition to large scale process chemistry, BlackStone Therapeutics is also a leader in cannabis-based research. Our research team has over 50 years of chemical experience ranging from academia, pharmaceutical, and industrial laboratories.
In addition to large scale process chemistry, BlackStone Therapeutics is also a leader in cannabis-based research. Our research team has over 50 years of chemical experience ranging from academia, pharmaceutical, and industrial laboratories.